1. Home
  2. BWA vs PODD Comparison

BWA vs PODD Comparison

Compare BWA & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BorgWarner Inc.

BWA

BorgWarner Inc.

HOLD

Current Price

$72.14

Market Cap

12.6B

ML Signal

HOLD

Logo Insulet Corporation

PODD

Insulet Corporation

HOLD

Current Price

$152.97

Market Cap

10.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWA
PODD
Founded
1987
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.6B
10.3B
IPO Year
1995
2007

Fundamental Metrics

Financial Performance
Metric
BWA
PODD
Price
$72.14
$152.97
Analyst Decision
Buy
Buy
Analyst Count
15
21
Target Price
$59.33
$341.48
AVG Volume (30 Days)
3.6M
1.4M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
1.25%
N/A
EPS Growth
N/A
N/A
EPS
1.16
1.30
Revenue
$14,316,000,000.00
$2,708,100,000.00
Revenue This Year
$1.54
$24.55
Revenue Next Year
$3.54
$19.18
P/E Ratio
$66.41
$112.59
Revenue Growth
1.63
30.73
52 Week Low
$32.44
$140.63
52 Week High
$78.82
$354.88

Technical Indicators

Market Signals
Indicator
BWA
PODD
Relative Strength Index (RSI) 61.68 44.35
Support Level $52.03 $143.11
Resistance Level N/A $205.95
Average True Range (ATR) 2.85 5.71
MACD 0.56 1.75
Stochastic Oscillator 63.97 66.14

Price Performance

Historical Comparison
BWA
PODD

About BWA BorgWarner Inc.

BorgWarner is a tier one supplier of turbo and thermal management technologies, drivetrain systems, powerdrive systems, and battery and charging systems mostly to automotive original equipment manufacturers. Its products aim to move a vehicle with as few electrons as possible, resulting in cleaner, cost-optimized, and more-efficient vehicles. Foundational products, the combustion vehicle business, contributes more than 80% to group revenue while BorgWarner transitions to becoming an electric vehicle-centric parts supplier (e-business). In 2024, 23% of the company's revenue was sourced from Volkswagen and Ford. Revenue is well diversified geographically, with approximately a third each generated in North America, Europe, and Asia.

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Share on Social Networks: